Close

IMGN Financial Facts

Net loss: -44.73M
Total operating expenses: 46.5M
See Full Income Statement

Accumulated deficit: -898.42M
Total current liabilities: 56.23M
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 4/25/24 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +73.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +51.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/12/24 Q423 N/A$0.13 N/A N/A$129.48M N/A N/A N/A
2/9/24 Q423 N/A$0.13 N/A N/A$129.48M N/A N/A N/A
11/2/23 Q323 $0.10$0.04 +$0.06$113.4M$103.68M N/A Details
2/25/22 Q421 -$0.17N/A N/A $28M$85.8M = Details
7/31/23 Q223 -$0.02-$0.13 +$0.11$77.4M$49.15M N/A Details
1/30/15 Q215 $0.16-$0.05 +$0.21$48.3M$37.3M N/A Details
2/12/21 Q420 $0.16-$0.10 +$0.26$85.8M$37.09M = Details
11/3/17 Q317 -$0.61-$0.19 -$0.42$8.5M$33.62M = Details